"","scenario","cases","severe_disease","hosp","death","YLL"
"1","25% prioritisation"," -15,543 (-0.2%)","  -1,334 (-4.7%)","  -2,679 (-2%)","    -154 (-7.5%)","  -1,407 (-5.1%)"
"2","50% prioritisation"," -13,656 (-0.1%)","  -1,373 (-4.8%)","  -2,726 (-2%)","    -159 (-7.8%)","  -1,451 (-5.2%)"
"3","75% prioritisation"," -12,513 (-0.1%)","  -1,384 (-4.9%)","  -2,734 (-2%)","    -161 (-7.8%)","  -1,463 (-5.3%)"
"4","booster at three months (at risk only)"," -96,437 (-1%)","  -6,331 (-22.3%)"," -12,491 (-9.3%)","    -710 (-34.5%)","  -6,516 (-23.6%)"
"5","additional primary doses"," -23,724 (-0.2%)","  -1,434 (-5.1%)","  -3,033 (-2.3%)","    -161 (-7.8%)","  -1,494 (-5.4%)"
"6","additional booster doses","-123,242 (-1.3%)","  -6,366 (-22.4%)"," -13,276 (-9.9%)","    -691 (-33.6%)","  -6,450 (-23.3%)"
"7","broaden to <18 pregnant individuals"," -23,724 (-0.2%)","  -1,434 (-5.1%)","  -3,033 (-2.3%)","    -161 (-7.8%)","  -1,494 (-5.4%)"
